Vous êtes sur la page 1sur 2

Report Status: Final

GARCIA DURAN, PALOMA


Patient Information

Specimen Information

Client Information

GARCIA DURAN, PALOMA

Specimen: DL539570R
Requisition: 0000018

IRV00FAX
Client #: 54860190
CHI ST LUKE'S OCC HLTH/SAFETY
6720 BERTNER AVE # B-1G040
HOUSTON, TX 77030-2604

DOB: 08/15/1987
AGE: 28
Gender: F
Phone:
NG
Patient ID: 15105520

Collected:
Received:
Reported:

05/25/2016 / 15:43 CDT


05/25/2016 / 15:43 CDT
05/27/2016 / 13:20 CDT

Test Name
In Range
Out Of Range
MMR (IGG) PANEL (MEASLES, MUMPS, RUBELLA)
MEASLES ANTIBODY (IGG)
1.81
Index
Explanation of Test Results
----------------------------------< or = 0.90
Negative - No Rubeola (Measles) IgG
Antibody detected
0.91 - 1.09
Equivocal
> or = 1.10
Positive - Rubeola (Measles) IgG
Antibody detected

Reference Range

Lab

index

IG

Positive results suggest recent or previous infection


with Measles (Rubeola) virus and imply immunity.
Patients exhibiting equivocal results should be
retested in one month, if clinically indicated.
MUMPS VIRUS
ANTIBODY (IGG)
1.37
index
Index
Interpretation
< or = 0.90
Negative
0.91-1.09
Equivocal
> or = 1.10
Positive
A positive result indicates that the patient has antibody
to mumps virus. It does not differentiate between an
active or past infection. The clinical diagnosis must
be interpreted in conjunction with the clinical signs
and symptoms of the patient.

IG

RUBELLA IMMUNE STATUS


RUBELLA ANTIBODY (IGG)
Value
----< or = 0.90
0.91-1.09
> or = 1.10

IG
2.93
Interpretation
-------------Not consistent with Immunity
Equivocal
Consistent with Immunity

The presence of rubella IgG antibody suggests


immunization or past or current infection with
rubella virus.
HEPATITIS B SURFACE
NON-REACTIVE
ANTIBODY QL
REACTIVE
VARICELLA ZOSTER VIRUS
index
ANTIBODY (IGG)
< OR = 0.90
Index
Explanation of Results
-----------------------------< or = 0.90
Negative - No VZV IgG Antibody detected
0.91 - 1.09
Equivocal
> or = 1.10
Positive - VZV IgG Antibody detected

RGA
IG

A positive result indicates that the patient


has antibody to VZV but does not differentiate
between infection (active or past) and vaccination.
The clinical diagnosis must be interpreted in
conjunction with the clinical signs and symptoms of

CLIENT SERVICES: 866.697.8378

SPECIMEN: DL539570R

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.

PAGE 1 OF 2

Report Status: Final


GARCIA DURAN, PALOMA
Patient Information

Specimen Information

Client Information

GARCIA DURAN, PALOMA

Specimen:
Collected:
Received:
Reported:

Client #: 54860190

DOB: 08/15/1987
AGE: 28
Gender: F
Patient ID: 15105520
Test Name

DL539570R
05/25/2016 / 15:43 CDT
05/25/2016 / 15:43 CDT
05/27/2016 / 13:20 CDT

In Range
Out Of Range Reference Range
the patient. This assay reliably measures immunity
due to previous infection but may not always be
sensitive enough to detect antibodies induced by
vaccination. Thus, a negative result in a vaccinated
individual does not necessarily indicate
susceptibility to VZV infection.

QUANTIFERON(R)-TB GOLD

NEGATIVE
NEGATIVE
Negative test result. M. tuberculosis complex
infection unlikely.
NIL
0.09
IU/mL
MITOGEN-NIL
>10.00
IU/mL
TB-NIL
<0.00
IU/mL
The Nil tube value is used to determine if the patient
has a preexisting immune response which could cause a
false-positive reading on the test. In order for a
test to be valid, the Nil tube must have a value of
less than or equal to 8.0 IU/mL.

Lab

RGA

The mitogen control tube is used to assure the patient


has a healthy immune status and also serves as a
control for correct blood handling and incubation. It
is used to detect false-negative readings. The mitogen
tube must have a gamma interferon value of greater
than or equal to 0.5 IU/mL higher than the value of
the Nil tube.
The TB antigen tube is coated
specific antigens. For a test
positive, the TB antigen tube
value must be greater than or

with the M. tuberculosis


to be considered
value minus the Nil tube
equal to 0.35 IU/mL.

For additional information, please refer to


http://education.questdiagnostics.com/faq/QFT
(This link is being provided for informational/
educational purposes only.)
PERFORMING SITE:
IG
RGA

QUEST DIAGNOSTICS-IRVING, 4770 REGENT BLVD., IRVING, TX 75063 Laboratory Director: ROBERT L BRECKENRIDGE,MD, CLIA: 45D0697943
QUEST DIAGNOSTICS HOUSTON, 5850 ROGERDALE ROAD, HOUSTON, TX 77072-1602 Laboratory Director: JULIA KENNY, M.D., CLIA: 45D0660150

CLIENT SERVICES: 866.697.8378

SPECIMEN: DL539570R

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics.

PAGE 2 OF 2